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Health Economics. 2018;1–12.Abstract
Each year, the UK records 25,000 or more excess winter deaths, primarily
among the elderly. A key policy response is the “Winter Fuel Payment”
(WFP), a labelled but unconditional cash transfer to households with a
member above the female state pension age. The WFP has been shown to raise
fuel spending among eligible households. We examine the causal effect of the
WFP on health outcomes, including self‐reports of chest infection, measured
hypertension, and biomarkers of infection and inflammation. We find a robust,
6 percentage point reduction in the incidence of high levels of serum fibrino-
gen. Reductions in other disease markers point to health benefits, but the esti-
mated effects are less robust.
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Each year, the UK experiences excess winter mortality (EWM). In 2014/2015, the number of excess winter deaths in
England and Wales was estimated at 43,900, the highest level since 1999. EWM has also been documented in Europe
(Eng & Mercer, 1998; Keatinge & Donaldson, 1995; Kunst, Looman, & Mackenbach, 1993; Mackenbach, Kunst, &
Looman, 1992; Rose, 1966), the USA (Kloner, Poole, & Perritt, 1999; Lanska & Hoffmann, 1999), and Asia (Chen,
1993; Ornato, Siegel, Craren, & Nelson, 1990). Most EWM occurs among the elderly and is due to respiratory and cir-
culatory diseases (Donaldson, 2010; Lloyd, 2013; ONS Statistical Bulletin 2014/2015).1 In addition to EWM, cold
weather is associated with increased demands on health care systems through increased incidence of illness requiring
hospitalisation or other treatment.
Although outdoor temperatures may play a role in EWM,2 living in a cold indoor environment has a direct impact
on the health of elderly people (Dear & McMichael, 2011; Marmot, Geddes, Bloomer, Allen, & Goldblatt, 2011; Rudge- - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -
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s attributable to respiratory disease and 22.5% to cardiovascular disease (ONS Statistical Bulletin 2014/
utdoor cold temperatures and mortality or morbidity is well documented in the epidemiological litera-
lkinson et al., 2001).
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2 CROSSLEY AND ZILIO& Gilchrist, 2007; Wilkinson, Armstrong, & Landon, 2001).3 In the UK, a key policy response to EWM is the Winter
Fuel Payment (WFP). The WFP is a labelled but unconditional cash transfer to households containing an older person
(male or female) above the female state pension age. The stated intent of the policy is to help the elderly deal with the
cost of keeping their dwelling warm (Kennedy & Parkin, 2016; Lloyd, 2013), and the labelling of this cash transfer has
been shown to be effective in inducing eligible households to increase fuel spending (Beatty, Blow, Crossley, & O'Dea,
2014).4 However, the key policy question is whether the WFP improves health of elderly people living in eligible house-
holds, and there is little evidence on this point.
The female state pension age, and hence the age cut‐off for WFP eligibility, was 60 prior to 2010. It then began to
increase so that it will equal the male state pension age of 65 in 2018, and then both will rise to 67 by 2028. Most EWM
occurs among individuals over 75, leading Lloyd (2013) to propose that increases in the eligibility age could reduce the
financial cost of the WFP with minimal if any reduction in health benefits. But there has been no direct evidence on
the health benefits foregone through recent increases in the age cut‐off or health benefits that may be lost through fur-
ther increases.
This paper reports the first tests for health benefits of the WFP based on individual‐level data. We measure health
outcomes in the Health Surveys for England (HSE), the Scottish Health Survey (SHeS), and the English Longitudinal
Study on Ageing (ELSA). These studies include nurse visits, allowing us study biomarkers and physical measures as
well as self‐reports. To estimate the causal effect of the WFP, we follow Beatty et al. (2014) in employing a regression
discontinuity design (RDD). The RDD is thought to be the most convincing of quasi‐experimental designs (Lee &
Lemieux, 2010).5 An RDD is possible where there is cut‐off in eligibility for treatment, as there is for the WFP: In
the period we study, households with no member aged 60 or above are ineligible.6 An RDD estimates the causal effect
of treatment by comparing outcomes just below and above the eligibility cut‐off. It estimates a local average treatment
effect—at the eligibility cut‐off. Thus, our design estimates the causal effect of the WFP on the health of individuals
living in households where the oldest member of the household is 61. This is precisely the age group that lost any
health benefits of the WFP as the eligibility age was incrementally increased from 2010, so our empirical strategy
directly answers a key policy question.
To the best of our knowledge, Iparraguirre (2014) is the only prior assessment of the health benefits of the WFP.
Using aggregate mortality data, Iparraguirre documents a decline in EWM in 2000/2001, coincident with the introduc-
tion of the universal WFP.7 EWM fluctuates significantly from year‐to‐year with changing winter weather conditions
and viral environment. Using time‐series econometric techniques, Iparraguirre finds a structural break in the EWM
time series for England and Wales in 2000/2001 and estimates that half of the reduction in the EWM in that year
can be attributed to the introduction of the WFP. This is an important finding, but it does rest on the ability of the
econometric methods to distinguish the policy effects from the very substantial year‐on‐year fluctuations in EWM.
Moreover, the aggregate EWM time series is necessarily silent on health effects that may precede mortality, and on
benefits to particular groups. We add to the evidence base significantly by using a convincing quasi‐experimental
design in conjunction with individual level data; by considering a variety of measures of circulatory and respiratory ill-
ness, including biomarkers8; and by testing for health benefits particularly among the group that have been made inel-
igible by recent changes to the age cut‐off.
We estimate the effect of the WFP on circulatory and respiratory illness measured four ways: self‐reports of chest
infection, nurse‐measured hypertension, and two blood biomarkers of infection and inflammation. Our principal3Wilkinson et al. (2001) show that deaths attributable to cardiovascular diseases are 23% higher in winter than the rest of the year and give evidence of
a positive association of the EWM with the age of the property and the thermal inefficiency of the buildings. Rudge and Gilchrist (2007) find that their
fuel poverty index that includes an energy efficiency rates and income is a strong predictor of the excess winter morbidity measured with number of
emergency respiratory hospital admissions.
4Beatty et al. (2014) estimate that eligible households spend 47% of their WFP on fuel. If the payment was treated as other income, eligible household
would be expected to spend 3% of the payment on fuel.
5The RDD was first introduced in the education literature (see Thistlethwaite & Campbell, 1960) and has been widely adopted in economics (Lee &
Lemieux, 2010)
6Take‐up of the WFP is very high, so that there is little difference between eligibility and receipt (see Beatty et al. (2014) for further discussion).
7The WFP was introduced in 1997, but it was initially means‐tested and the payment significantly smaller. In 2000/2001, it took its current form (a
universal payment to all households containing a person above the female state pension age of between 200 and 300 pounds).
8Biomarkers have been increasingly drawing attention in the economic literature as an objective measure of health and a complement of self‐reported
health measures (see Evans & Garthwaite, 2014; Jürges, Kruk, & Reinhold, 2013; Michaud, Crimmins, & Hurd, 2016)
CROSSLEY AND ZILIO 3finding is that, among those living in a household that just qualifies for the payment, the WFP leads to a 6 percentage
point reduction in the incidence of high levels of serum fibrinogen (on a base of 12%). High levels of fibrinogen are
considered to be a marker of current infection and are also associated with chronic pulmonary disease. This effect is
statistical significant (p < .01) and very robust. For the other health measures we consider, although point estimates
suggest health benefits, the estimated effects are less robust to changes in sample or specification, and rarely statisti-
cally significant at conventional levels.
In the next section, we provide further detail on our data, outcomes measures, identification strategy, and methods.
Section 3 presents our results. Section 4 contains additional discussion of the findings.2 | DATA AND METHODS
2.1 | Data
The analysis reported in this paper is based on data from the HSE (2001, 2003, 2004, 2005, 2006, and 2009; see NatCen,
2010a, 2010b, 2010c, 2011, 2015),9 the SHeS (2003, 2008, and 2009; see JHSU, 2016 and ScotCen, 2016a, 2016b), and the
ELSA (Wave 2, 2004–2005, and Wave 4, 2008–2009; see Marmot et al., 2017). The HSE and the SHeS are annual cross‐
sectional surveys of the health conditions of the population in England and Scotland. ELSA is a longitudinal survey
that captures the population in England aged 50 and over. The ELSA sample is derived from the 1998, 1999, and
2001 HSE. In all three surveys, a face‐to‐face interview is followed by a nurse visit. In the interview, the respondents
answer questions on their general health, smoking status and alcohol consumption, and other individual characteristics
such as education and employment status. After the interview, an appointment for the nurse visit is arranged. In the
visit, a trained nurse asks questions on the health condition of the respondent, takes blood and saliva samples, and
reads the blood pressure and several other measures (height, weight, waist, hip, lung function, and grip strength).
Blood samples are sent to an external laboratory for analysis. ELSA, HSE, and SHeS data contain several biomarkers
that are recovered from the analysis of the blood samples. Among the biomarkers reported, there are two that are use-
ful for our analysis because they are correlated with inflammation processes and infection and are markers of circula-
tory and respiratory illness. These are C‐reactive protein (CRP) and fibrinogen.
Over the period 2003–2009, the female state pension age was 60,10 and so any household with a member over age 60
qualified for the WFP. Following Beatty et al. (2014), we restrict the sample to single men and couples in which the
man is the oldest in the household. We discard single women and couples in which the woman is the oldest member
of the household because such households qualify for the WFP and the woman's state pension simultaneously. In
household in which the oldest member is male, eligibility for the WFP and the first state pension are not coincident.
Thus, we avoid any confounding effect of receipt of the state pension on the fuel expenditure and the health outcomes
of the elderly. We have not identified any other potential confounding policy directed at persons aged 60 and above.
For example, free flu vaccinations are offered to elderly aged 65 or over (Department of Health, 2000).2.2 | Health outcomes
We study four measures of circulatory and respiratory illness:
(a) self‐reports of chest infection in the last 3 weeks;
(b) hypertension;
(c) serum values of CRP in excess of 10;
(d) serum values of fibrinogen equal or in excess of 4.
During the nurse visit, respondents are asked whether they have experienced any respiratory infection in the
preceding 3 weeks (influenza, pneumonia, bronchitis, or a severe cold). This self‐reported outcome is available only
in ELSA and SHeS.
Our second outcome is hypertension, a risk factor for strokes and heart attacks. The World Health Organization
defines hypertension as systolic blood pressure of 140 mm Hg or above and/or diastolic blood pressure of 90 mm9HSE 2001 contains hypertension measure and self‐reports of chest infection only (not the biomarkers).
10In the same period, the male state pension age was 65.
4 CROSSLEY AND ZILIOHg or above (World Health Organization, 2013). Repeated exposure to a cold environment results in an increase in
the blood pressure, and high values of systolic and/or diastolic blood pressure (hypertension) is a predictor of heart
disease and stroke (Collins, Easton, Belfield‐Smith, Exton‐Smith, & Pluck, 1985; Collins et al., 1990; Fraser, 1986;
Hofman, Feinleib, Garrison, & van Laar, 1983; Wilson et al., 1998). In our sample, around the cut‐off age for WFP
eligibility, about 35% of respondents are hypertensive.
The other outcomes in our study are CRP and fibrinogen, two acute‐phase biomarkers. Serum concentrations of
these two biomarkers increase sharply during an inflammatory process. CRP is a blood plasma protein that is
indicative of inflammation and infection and a risk predictor of cardiovascular disease. It is considered an indicator
of bacterial infection, pneumonia, and tissue damage (Pepys & Hirschfield, 2003; Pearson et al., 2003; Simon,
Gauvin, Amre, Saint‐Louis, & Lacroix, 2004; Tillett & Francis, 1930). The median of CRP in our sample is
1.7 mg/L, but its distribution is highly skewed. The value rises within few hours of disease onset. Inflammation
and bacterial infection can produce a rise in CRP values up to 1,000‐fold (Gruys, Toussaint, Niewold, & Koopmans,
2005; Pepys & Hirschfield, 2003). Fibrinogen is a coagulation protein produced by the liver that helps the body in
the formation of blood clots. The normal range of fibrinogen is 2–4 g/L, but the concentration increases up to
threefold in the presence of an inflammatory process, infection, or tissue damage (Fenger‐Eriksen, Lindberg‐Larsen,
Christensen, Ingerslev, & Sørensen, 2008; Gruys et al., 2005; Schmaier, 2012). High concentrations of fibrinogen are
also strongly associated with chronic obstructive pulmonary diseases and moderately with coronary heart diseases
(Danesh et al., 2005; Duvoix et al., 2013; Mannino et al., 2015). In the epidemiological literature, a value of the
CRP in excess of 10 is taken as evidence that a person has an active infection or inflammatory process. Because
high values of CRP or fibrinogen are considered evidence of current infection, Epidemiologists often discard observa-
tions with these high values in order to focus on chronic processes (Pearson et al., 2003).
However, as our interest is whether the WFP plays a role in reducing the incidence of a respiratory or circulatory
disease among the elderly, extreme values (in excess of 10 for CRP) are the appropriate object of our analysis. The
epidemiological literature has not defined an equivalent disease threshold for fibrinogen, but we take values in excess
of the top the standard range (2–4 g/L) as evidence of current infection or inflammation.2.3 | Regression discontinuity design
The RDD allows health outcomes to vary with the “forcing variable,” which is the age of the oldest person in the
household of subject i at the time of the interview t. Denote this by (Ait). The econometric model includes smooth
functions of the value of the forcing variable relative to the cut‐off age (Ait−60). It also includes an indicator (or
dummy) variable, Dit, for whether a respondent's household was eligible for the last WFP payment before the inter-
view at which health outcomes were measured. Finally, it includes additional covariates Xit, to increase the precision
of the estimator by capturing individual background variation in health (unrelated to the WFP).11 Our covariates
include type of households (single or couple), individual characteristics (gender, smoker status, alcohol consumption,
education, income, and employment status), anthropometric measurements (body mass index and waist circumfer-
ence), dummies for each wave (year) of each survey, and month of nurse visit.
Thus, the econometric model is
Hit ¼ β0 þ f Ait−60ð Þ þ τDit þ f Ait−60ð Þ×Dit þ Xitγþ eit:
We employ both linear and quadratic functions for f(). The model is estimated by ordinary least squares. Note that
all of the health measures (Hit) we consider are binary so that E[Hit] = Prob(Hit = 1), and this is a linear probability
model. The parameter of interest is τ, which measures the local causal effect of the WFP on Prob(Hit = 1), around the
cut‐off. Formally,11The assumption behind the RDD is that all health determinants apart from WFP eligibility should evolve smoothly with Ait, including (but not lim-
ited to) the covariates Xit. For the covariates Xi, we can test this by estimating an RDD in Xi. There should be no discontinuity in the Xi at the 60 or,
equivalently, observables should be balanced between eligible and not eligible in the region of the cut‐off (analogous to covariate balance in a
randomised trial). We have tested this and cannot reject for balance for any of the included covariates Xi. This implies that the point estimate of
the treatment effect is not affected by the inclusion of the covariates, which we confirm in our robustness checks. The covariates can, however,
improve precision by reducing the unexplained variation in the outcome variable (again, as in a randomised trial).
FIGURE 1 Effect of the Winter Fuel Payment on the probability of having a C‐reactive protein level larger than 10. Plotted points
represent the incidence of (C‐reactive protein > 10) by year of age of the oldest person in the subject's household, with best fit regression
lines to the left and right of the eligibility cut‐off. CRP = C‐reactive protein
CROSSLEY AND ZILIO 5τ ¼ lim
A↓60
E HitjAit ¼ 60;Xit ¼ x½ − lim
A↑60
E HitjAit ¼ 60;Xit ¼ x½ :
As the Hit are measures of illness, if the WFP improves health, τ should be negative. We report standard errors that
are robust to heteroscedasticity and clustering by the age in years of the oldest member of the respondent's household.
Because we look at multiple health outcomes, we also report p‐values adjustment for multiple testing using the
Romano–Wolf algorithm (Romano & Wolf, 2016).
The WFP was between £200 and £300 (about 300–450 U.S. dollars) during the period 2002–200912 when our data
were collected, and it was paid in November–December.13 Eligibility is determined by the age of the old household
member in the preceding September. In our data, ages are recorded in years. That means, the WFP status of some
households with the oldest member aged 60 or 61 can only be determined probabilistically (for details see the
Supporting Information).3 | RESULTS
We begin with the standard graphical presentation of the RDD in Figures 1–4. Each figure corresponds to one of our
four measures of circulatory and respiratory illness. The vertical axis measures the incidence of illness. The horizontal
axis measures the age of the oldest member of a respondent's household. Each plotted point is the average value of the
illness measure for a given age of oldest household member (in years). As our illness measures are binary, this mean is
an incidence (or empirical probability). The cut‐off for WFP eligibility (at age 61) is indicated in Figures 1–4 by the ver-
tical line, and separate least‐squares best‐fit lines are plotted to the left and the right of the cut‐off. A treatment effect is
indicated by a discontinuity between these two best‐fit lines at the cut‐off.
Three of the four figures indicate decline in illness incidence with WFP eligibility. The exception is self‐reported
chest infection. The plots also indicate that the paths of illness incidence across age of the old household member
are quite noisy, with significant year on year fluctuations. Although we have substantial sample sizes (each point rep-
resents about 400 observations), we are modelling relatively rare events (in our sample 5.5% of the elderly just below
the cut‐off present a CRP value larger than 10% and 12.5% a fibrinogen value in excess of four, see Table 1). To assess
the magnitudes and statistical significance of the discontinuities visible in these figures, we turn to formal RDD esti-
mates (as described above). These are reported in Table 2.12From 2000 to 2007, the WFP was £200 for most eligible households but £300 for households with an over‐80s member. In 2008, the WFP was tem-
porarily uplifted to £250 for over 60s and to £400 for over 80s, but this increase was reversed in the budget of March 2011. The sharp increase in the
payment at age 80 might seem to offer an opportunity for a second RDD, but our data are too sparse to the right of this cut‐off to implement this.
13Recipients receive a letter at the time of the payment indicating that the cash transfer is to help with the cost of heating their home.
FIGURE 3 Effect of the Winter Fuel Payment on the probability of having had a recent chest infection. Plotted points represent the
incidence of (self‐reported chest infection in the last 3 weeks) by year of age of the oldest person in the subject's household, with best fit
regression lines to the left and right of the eligibility cut‐off
FIGURE 2 Effect of the Winter Fuel Payment on the probability of having a fibrinogen level equal or larger than four. Plotted points
represent the incidence of (Fibrinogen ≥ 4) by year of age of the oldest person in the subject's household, with best fit regression lines to
the left and right of the eligibility cut‐off
6 CROSSLEY AND ZILIOIn Table 2, each column gives the estimate of the WFP effect on the health outcomes in our preferred specification
with linear functions of the forcing variable, f(), covariates, and a sample age window (for the age of the oldest mem-
ber in the household window) of 50 to 72 years. The point estimates suggest that the WFP improved the health of the
elderly at age 61, reducing all our measures of illness. Effect sizes are 1 to 6 percentage points.
However, the WFP only has a statistically significant effect at 5% level on having a high concentration of fibrin-
ogen. This finding is robust to the adjustment for multiple testing using the Romano–Wolf algorithm (see the third
line in Table 2). The WPF decreases the probability of a fibrinogen value in excess of 4 g/L by 5.8 percentage
points. As 12.5% of the elderly just below the cut‐off have a value of fibrinogen in excess of four, our estimate
implies a 46% reduction in the incidence of this measure of illness at the age cut‐off. Data on the CRP are noisier,
and the discontinuity effect at the cut‐off is not statistically significant at conventional levels. Nonetheless, the
magnitude of the WFP effect (1.3 percentage points) is sizeable and implies a 24% reduction in the incidence of
illness by this measure, again at the cut‐off.1414The fraction of elderly just below the age 61 cut‐off with CRP value larger than 10 is 5.5%.
FIGURE 4 Effect of the Winter Fuel Payment on the probability of having hypertension. Plotted points represent the incidence of
(hypertension) by year of age of the oldest person in the subject's household, with best fit regression lines to the left and right of the
eligibility cut‐off
TABLE 1 Descriptive statistics
Age window Median 90th percentile Prob(illness)
C‐reactive protein 58–63 1.7 7 Prob(CRP > 10) 0.055
Fibrinogen 58–63 3.1 4 Prob(Fib ≥ 4) 0.125
Hypertension 58–63 — — Prob(hypertension) 0.353
Self‐reported chest infection 58–63 — — Prob(chest infection) 0.101
Note. C‐reactive protein, fibrinogen, hypertension, and self‐reported chest infection. Observations with a fractional probability of being eligible to the Winter
Fuel Payment are dropped. CRP = C‐reactive protein
TABLE 2 The impact of the Winter Fuel Payment on predictors of infection
Effect of the Winter Fuel Payment on fibrinogen, C‐reactive protein, self‐reported chest infection, and hypertension
Fibrinogen
C‐reactive
protein
Self‐reported
infection Hypertension
Causal effect of eligibility [95% confidence interval] −058*** [−.080, −036] −013 [−040, .015] −.024* [−050, .001] −018 [−045, .009]
Minimum detectable effect (at 80% power) ±0.028 ±0.034 ±0.032 ±0.034
Unadjusted p value (adjusted for multiple testing) 0.000 (0.022) 0.418 (0.220) 0.058 (0.091) 0.207 (0.119)
Number of observations 3,974 4,517 4,569 6,295
Age window 55–65 55–65 55–65 55–65
Note. Standard Errors clustered by age of the oldest household member. The regression discontinuity designs have a linear specification in the age of the oldest
member in the household. Additional covariates are type of household, gender, smoker status, alcohol consumption, body mass index, waist circumference,
education, income, employment status, month of nurse visit, and survey‐wave dummies.
***p < .01. **p < .05. *p < .1.
CROSSLEY AND ZILIO 7In column 3, we report the effect on self‐reporting a chest infection in the last 3 weeks, and in column 4, we report the
effect on the incidence of hypertension. The effects are about 2 percentage points, but neither is statistically significant at
5% level.
The effect on incidence of fibrinogen above the normal range is both the largest point estimate and the most pre-
cisely estimate effect. To get an idea of the power of our tests, we calculated, for each outcome, the minimum effect size
we would have 80% power to detect. These are displayed in the second row of Table 2. Although we have quite large
samples sizes, minimum detectable effects are quite large. This is partly because we are examining the incidence of
extreme values, and partly because we only have clean identification of treatment effects at the eligibility cut‐off and
must model the evolution of illness incidence on either side of the cut‐off.
FIGURE 5 Effect of the Winter Fuel Payment on the poor health index. Plotted points represent the mean of the poor health index by year
of age of the oldest person in the subject's household, with best fit regression lines to the left and right of the eligibility cut‐off
8 CROSSLEY AND ZILIOTo increase our confidence in the main result reported in Table 2, we conducted several robustness
checks including: omitting covariates, varying the data window or the degree of the polynomial in the running
variables, and omitted those households whose eligibility could only be determined probabilistically. Our main result
of a significant effect on extreme values of fibrinogen and is robust to all of these variations. We also conducted
falsification tests. We found no discontinuity in the incidence of extreme values of fibrinogen at placebo age cut‐offs.
We also found no effect of WFP eligibility on the median value of fibrinogen—indicating that effect is just on
the incidence of extreme values, indicative of acute illness. Finally, a potential concern is that even though no
member of our sample qualifies for a state pension at the eligibility cut‐off, there could still be discrete changes
in labour supply (that is, retirement) when a man reaches age 60 (see Beatty et al., 2014 for further discussion).
We address this in our main estimates by including employment status in our additional covariates. Additionally,
our balance tests include treating employment status as the outcome in an RDD regression analogous to those we
estimate for health outcomes. We find no evidence of discrete change in employment status at the WFP eligibility
cut‐off. Full details of our robustness checks, falsification tests, and balance tests are available in the Supporting
Information.
Turning to subsample analysis, we follow Kling, Liebman, and Katz (2007) and create a poor health index and imple-
ment the RDD on this new measure. This both improves the statistical power of detecting effects of the same sign and
reduces problems of multiple testing. The poor health index combines our indicators of cardiovascular and respiratory
diseases in a single measure. We exclude self‐reports of chest infection and focus on our binary objective measures,
serum‐fibrinogen in excess of four, serum‐CRP in excess of 10, and hypertension.15 For each of these outcomes, we cal-
culate the z‐scores subtracting the mean of the group of people just below the eligibility cut‐off and dividing by the stan-
dard deviation of the same group. The poor health index is the average of the three z‐scores, and a low value of the index
is evidence of better health.
We first present the impact of the WFP on the poor health index graphically in Figure 5. As in the figures
reported previously, a discontinuity at the eligibility cut‐off is evidence of an effect of the WFP on health. The data
in Figure 5 are still noisy as in the analysis of the single objective health outcomes, but there is a visible drop in
the poor health index around the eligibility cut‐off, indicating improved health.
In Table 3, we show the size of the effect of the WFP on the poor health index for different subsamples. An esti-
mate for the full sample is presented in column 1 and shows a statistically significant decrease in the poor health index
of 0.23 standard deviations. In the Supporting Information, we show that the reduction of the poor health index is in
the range of 0.2 to 0.51 standard deviations and robustly statistically significant at 5% level when we change our RDD
specification in the ways listed above.15Self‐reports of chest infection are the only measure that does not show a clear pattern in the data and is not reported in HSE.
TABLE 3 Impact of the Winter Fuel Payment on the poor health index in subgroups
All sample Colder months only Low‐income (first quartile) Low education
−232*** [−384, −081] −384* [−786, .017] −044 [−422, .334] −485*** [−818, −152]
N = 3481 N = 2351 N = 786 N = 980
Note. Standard Errors clustered by age of the oldest member level; 95% confidence interval. Linear specification in age of the oldest household member. Age
window: 55–65. Colder months exclude June, July, August, and September. Low‐educated highest qualification reported: No qualification, NVQ Level 1,
NVQ Level 2. Additional covariates are type of household, gender, smoker status, alcohol consumption, body mass index, waist circumference, education,
income, employment status, month of nurse visit, and survey‐wave dummies.
***p < .01. **p < .05. *p < .1.
CROSSLEY AND ZILIO 9In the second column of Table 3, we report the estimates on a sample, which excludes observations with a
nurse visit in summer. The rational is that we do not expect any beneficial effect of the WFP on health in the
summer months. Consistent with this expectation, we find a slightly larger reduction in the poor health index than
in the full sample (a point estimate of 0.38 standard deviations that is statistically significant at 10% level). Next,
we estimate the effect of the WFP on the poor health index for low‐income respondents (column 3). Beatty et al.
(2014) show a particularly significant increase in the fuel expenditure for poorer households. These households
should therefore experience larger health benefits. We find an effect magnitude of −0.04 standard deviations that
is not precisely estimated, in part because of the reduction in the sample size. Finally, we consider the effect of
WFP eligibility among low education respondents. Here, we find a very large and statistically significant effect
of around 0.49 standard deviations. For older households, education may be a better indicator of economic
resources than current income. Alternatively, low education households may be more susceptible to effect of the
labelling.4 | DISCUSSION
We find evidence to suggest that raising the cut‐off age for WFP eligibility has had a negative effect on the health of
individuals made ineligible. We find a robust and statistically significant effect for only one of the individual illness
measures we consider, though point estimates for all the markers we consider point in this direction. Reductions of 1
to 6 percentage points (for fairly rare events) are large effect sizes. Using a poor health index that combines our illness
markers, we find particularly large effects for low education individuals.
For healthcare providers, these results highlight the need to be sensitive to inadequate indoor heating as a
potential winter health risk, perhaps particularly among low education individuals who fall just short of eligibility
for the WFP.
For policy makers, our results suggest that the tightening of eligibility for the WFP that has come with increases to
the female state pension age may not have come without health costs. Our RDD estimates indicate a causal effect of the
WFP on the health of individuals living in households where the oldest member of the household is 61. This is pre-
cisely the age group that lost any health benefits of the WPF as the eligibility age was incrementally increased from
2010 (that is, the group that would have been eligible had the eligibility age not increased, but now is not). Our sub-
sample analysis, finding particularly large effect for low education individuals, may point to means testing as a better
way of rationing the programme. At a minimum, further research is needed to determine the loss of health benefits
associated with potential future increases in the eligibility age.ETHICAL STATEMENT
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